U50,488H depresses pulmonary pressure in rats subjected to chronic hypoxia

Journal of Cardiovascular Pharmacology

Volumn 47, Issue 4, 2006, Pages 594-598

  Pei, Jian Ming ^a   Sun, Xin ^a   Guo, Hai Tao ^a   Ma, Sai ^a   Zang, Yi Min ^a   Lu, Shun Yan ^a   Bi, Hui ^a   Wang, Yue Min ^a   Ma, Heng ^a   Ma, Xin Liang ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

488H; Hypoxic pulmonary hypertension; U50

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; KAPPA OPIATE RECEPTOR ANTAGONIST; NORBINALTORPHIMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART RIGHT VENTRICLE HYPERTROPHY; HYPOXIA; LUNG HEMODYNAMICS; LUNG PRESSURE; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; RAT; VASODILATATION;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANIMALS; ANOXIA; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERTENSION, PULMONARY; HYPERTROPHY, RIGHT VENTRICULAR; INJECTIONS, INTRAVENOUS; MALE; PERFUSION; PULMONARY ARTERY; PULMONARY CIRCULATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33748186515     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000211737.55583.15     Document Type: Article

References (8)

1. 3H]-U69593 binding sites in the rat heart by receptor binding studies. J Mol Cell Cardiol. 1991;23:1297-1302.
2. Bi H, Wang YM, Zhu MZ, et al. Effects of U50,488H on blood pressure and underlying mechanism in the rats. J Med Postgrad. 2004;17:404-407.
3. Michelakis ED, McMurtry MS, Wu XC, et al. Dichloroacetate, a metabolic modulator, prevents and reverses chronic hypoxic pulmonary hypertension in rats: role of increased expression and activity of voltage-gated potassium channels. Circulation. 2002;105:244-250.
4. ATP channel in the rats. Acta Physiol Sin. 2003;55:91-95.
5. Chen M, Pei JM, Li LS, et al. Relaxant effect of U50,488H on abdominal aortic artery in rat and its mechanism. Di-Si Junyi DaXue Xuebao. 2001;22:29-32.
6. Sun X, Zang YM, Wang YM, et al. Vasorelaxing effect of U50,488H on pulmonary artery in rats and underlying mechanism. Chin Heart J. 2004;16:513-516.
7. Pei JM, Chen M, Wang YM, et al. The inhibitory effects of κ-opioid receptor on cardiac hypertrophy. Chin Heart J. 2002;14:465-469.
8. Sun X, Ma S, Zang YM, et al. Vasorelaxant effect of U50,488H in pulmonary artery and underlying mechanism in rats. Life Sci. 2005; ePub-ahead of print.